SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-764315
Filing Date
2016-11-09
Accepted
2016-11-09 16:03:50
Documents
39
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d233753d10q.htm 10-Q 288313
2 EX-31.1 d233753dex311.htm EX-31.1 8853
3 EX-31.2 d233753dex312.htm EX-31.2 8780
4 EX-32 d233753dex32.htm EX-32 3994
  Complete submission text file 0001193125-16-764315.txt   2221017

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pvct-20160930.xml EX-101.INS 262852
6 XBRL TAXONOMY EXTENSION SCHEMA pvct-20160930.xsd EX-101.SCH 36586
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pvct-20160930_cal.xml EX-101.CAL 32378
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pvct-20160930_def.xml EX-101.DEF 114808
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pvct-20160930_lab.xml EX-101.LAB 278057
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pvct-20160930_pre.xml EX-101.PRE 182743
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36457 | Film No.: 161984201
SIC: 2834 Pharmaceutical Preparations